Renal Cell – IV Alpha Lipoid Acid, Low-Dose Naltrexone

Hi Shiningrice-

I’m not very experienced about advanced kidney cancer and Poly MVA. I have linked the Poly website testimonials below. Also, your therapy options will be limited with stage 4 cancer. I would try multiple therapies and make every effort to manage my cancer.

Poly MVA Kidney Cancer Testimonials

Good luck,

David Emerson

Hi Tony-

Several things. I am sorry to read of your stage 4 RCC. There are several evidence-based, non-toxic therapies that are cytotoxic to RCC as well as evidence-based integrative therapies- therapies that enhance the efficacy of chemotherapies. My point is that taking an integrative therapy approach is a middle ground- not conventional nor alternative. Something to consider.

Regarding the research linked below- 1) the ALA/LDN therapy was administered at a clinic in New Mexico. The study refers to intravenous vitamin C therapy as well as some sort of general “healthy lifestyle program” The clinic administers the therapies with dosing. You should find a clinic with experience with administering ALA/LDN therapy. Lastly, the clinic used imaging equipment- CT, PET, etc. Also important for tracking your progress.

My point is that there are many reasons to go to a clinic with experience administering ALA/LDN therapy.

Let me know if you have other questions.

Hang in there,

David Emerson

The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol

“In this case report, we describe the treatment of a 64-year-old male patient diagnosed with metastatic renal cell carcinoma (RCC) in June of 2008. In spite of a left nephrectomy and the standard oncological protocols, the patient developed a solitary left lung metastasis that continued to grow. He was informed that given his diagnosis and poor response to conventional therapy, any further treatment would, at best, be palliative. The patient arrived at the Integrative Medical Center of New Mexico in August of 2010. He was in very poor health, weak, and cachectic. An integrative program—developed by one of the authors using intravenous (IV) α-lipoic acid, IV vitamin C, low-dose naltrexone, and hydroxycitrate, and a healthy life style program—was initiated. From August 2010 to August 2015, the patient’s RCC with left lung metastasis was followed closely using computed tomography and positron emission tomography/computed tomography imaging. His most recent positron emission tomography scan demonstrated no residual increased glucose uptake in his left lung. After only a few treatments of IV α-lipoic acid and IV vitamin C, his symptoms began to improve, and the patient regained his baseline weight. His energy and outlook improved, and he returned to work. The patient had stable disease with disappearance of the signs and symptoms of stage IV RCC, a full 9 years following diagnosis, with a gentle integrative program, which is essentially free of side effects. As of November 2017 the patient feels well and is working at his full-time job.”

Hi Roger-

First names only. In answer to your question about ALA and LDN as RCC therapy, though I have found a fair amount of research about ALA and LDN for various cancers, I have only found anecdotal research about RCC. I will add though, that there are other evidence-based, non-toxic therapies for RCC that are cytotoxic to RCC by themselves and/or integrative with conventional chemotherapy regimens.

David Emerson

David,

Interesting web page you have. I have RCC. Do you know where I can find further info on using ALA & LDN to combat Rcc?
Thanks very much,

Hi Gabriella,

First and foremost, I am sorry to learn of your husband’s metastatic RCC. I agree with your husband that Sutent therapy brings many health challenges with it. Several things-

I can’t provide “promising remedies.” I apologize for being so direct but my hope is that you will understand my approach. Yes, there are several evidence-based non-conventional therapies available to your husband but I can’t label any as “promising” at this stage.

Having said that, I will follow with the fact that I was end-stage myself(different cancer) after 4 years of conventional therapies back in ’94-’97. As you know, the advanced RCC patient who underwent ALA and low dose Naltrexone achieved excellent results. So yes, there are available therapies…I’m just tring to adjust your expectations.

I noticed that you registered for the general cancer coaching webinar. Experience has taught me that a spectrum of evidence-based therapies such as integrative and complementary therapies can be useful for survivors in your husband’s situation. If you haven’t watched the CC webinar, the program is comprized of anti-cancer nutrition, supplementation, detox. therapies, etc. that are then followed up by specific therapies for your specific cancer.

An example would be a series of integrative therapies for RCC. For example, I would offer enhancing the anti-angiogenic properties of sorafenib with a non-toxic supplement called curcumin (I have been supplementing with curcumin for over ten years)

Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma.
“In particular, in BEL-7402 cells induced tumor xenograft, SCN treatment displayed the obviously enhanced inhibitory effect on tumor progression over free drug monotherapy or their physical mixture, with significantly increased antiproliferation and antiangiogenesis capability. Thereby, the codelivered nanoassemblies of sorafenib and curcumin provided a promising strategy to enhance the combinational therapy of HCC.”

At the same time I would encourage you to discuss with your oncologist non-curative therapies for your husband’s mets that could give him both the QOL and time needed for the integrative and complementary therapies to work.
Evaluating Cryoablation of Metastatic Lung Tumors in Patients–Safety and Efficacy: The ECLIPSE Trial–Interim Analysis at 1 Year.
” Local tumor control rates were 56 of 58 (96.6%) and 49 of 52 (94.2%) at 6 and 12 months, respectively. Patient’s quality of life was unchanged over the follow-up period. One-year overall survival rate was 97.5%. The rate of pneumothorax requiring chest tube insertion was 18.8%. There were three Common Terminology Criteria for Adverse Events grade 3 procedural complications during the immediate follow-up period (pneumothorax requiring pleurodesis, noncardiac chest pain, and thrombosis of an arteriovenous fistula), with no grade 4 or 5 complications.
CONCLUSION:
Cryoablation is a safe and effective treatment for pulmonary metastases with preserved quality of life following intervention.”

My experience is tha conventional oncology is limited, meaning they are focused on “standard-of-care” therapies. Your husband may be able to benefit greatly with both FDA approved and evidence-based but not FDA approved therapies.

Let me know if you have any questions. Hang in there,

David Emerson
Cancer Surivivor
Cancer Coach
Director PeopleBeatingCancer